Tamiflu oseltamivir: Marketed

GILD and partner Hoffmann-La Roche Inc. published in the Pediatric Infectious Disease Journal results of a U.S. Phase III study in 695 children aged 1-12. Of 452 patients infected with influenza, 67 ...